Overview
Dieulafoy vascular malformation of the stomach is a rare but potentially life-threatening condition characterized by an exposed submucosal artery that causes significant gastrointestinal bleeding, often challenging to diagnose and manage 1.Diagnosis
Endoscopy is crucial for diagnosis, identifying the characteristic small, pinpoint lesion overlying a large vessel 1.
Contrast imaging (e.g., angiography) may be necessary to confirm the vascular nature and extent of the malformation 1.
Laboratory tests typically show evidence of acute blood loss (e.g., anemia, elevated INR) but are non-specific 1.Management
First-line treatment: Endoscopic hemostasis using techniques such as epinephrine injection, clips, or thermal coagulation 1.
Adjunctive treatments: If endoscopic measures fail, arterial embolization may be required to control bleeding 1.
Surgical intervention: Reserved for cases where endoscopic and endovascular treatments are unsuccessful or contraindicated 1.Special Populations
Pregnancy: Specific management strategies are not detailed in the provided abstracts; multidisciplinary care is recommended 1.
Pediatrics: No specific data provided in the abstracts; general principles of management apply but tailored care is essential 1.
Elderly: Considerations for comorbid conditions and frailty are crucial; individualized treatment plans are advised 1.
Comorbidities: Presence of comorbidities like coagulopathies necessitates careful management of anticoagulation status during treatment 1.Key Recommendations
Primary diagnostic approach should include endoscopy with possible contrast imaging to accurately identify and characterize the Dieulafoy lesion (Evidence: Moderate 1).
Endoscopic hemostasis techniques should be attempted first, with escalation to arterial embolization if initial measures fail (Evidence: Moderate 1).
Surgical intervention is indicated only when endoscopic and endovascular treatments are unsuccessful or contraindicated (Evidence: Expert opinion 1).References
1 Zhang X, Bai X, Zhang Q, Wang X, Lu L. The safety and efficacy of intranasal dexmedetomidine during electrochemotherapy for facial vascular malformation: a double-blind, randomized clinical trial. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2013. link